Koziol Natalie A, Butera Christiana D, Hsu Lin-Ya, Pereira Silvana Alves, Dusing Stacey C
Nebraska Center for Research on Children, Youth, Families and Schools, University of Nebraska-Lincoln, Lincoln, NE, USA.
Division of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, CA, USA.
Dev Med Child Neurol. 2025 Aug;67(8):1063-1074. doi: 10.1111/dmcn.16259. Epub 2025 Feb 14.
To evaluate the construct validity and responsiveness of the Gross Motor Function Measure-66 Item Set (GMFM-66-IS), a standardized criterion-referenced observational measure, for use with children younger than 24 months with or at high risk for cerebral palsy (CP).
Non-experimental integrative data analysis was performed on secondary data from three clinical trials involving children with or at high risk for CP (n = 79, 42 males, mean corrected age = 11.3 months [SD = 4.9]), and one observational study of typically developing children (n = 32, 14 males, mean age = 5.7 months [SD = 0.8]). The GMFM-66-IS and comparator instrument (gross motor subtest from the Bayley Scales of Infant and Toddler Development, Third Edition [Bayley-III] or Bayley Scales of Infant and Toddler Development, Fourth Edition [Bayley-4], depending on the study) were administered at baseline and 3 months later. Comparator groups were based on neurological impairment, clinical rating of gross motor change, and CP status. Correlations (r) and regression-adjusted standardized mean differences (Hedges' g) were computed.
GMFM-66-IS and Bayley scores were correlated at baseline (r = 0.83), 3 months later (r = 0.88), and across time (r = 0.83). Children with mild impairment had higher mean GMFM-66-IS scores at baseline (g = 0.87) and 3 months later (g = 0.95). Children rated as demonstrating greater than expected gross motor change had larger mean GMFM-66-IS change scores than children demonstrating less than expected change (g = 0.62). Typically developing children had larger mean GMFM-66-IS change scores (g = 1.00).
GMFM-66-IS scores were supported by evidence of strong construct validity and moderate responsiveness.
评估粗大运动功能测量66项量表(GMFM - 66 - IS)的结构效度和反应度,该量表是一种标准化的标准参照观察性测量工具,用于24个月以下患有脑瘫(CP)或有CP高风险的儿童。
对来自三项临床试验的二次数据进行非实验性综合数据分析,这些试验涉及患有CP或有CP高风险的儿童(n = 79,42名男性,平均矫正年龄 = 11.3个月[标准差 = 4.9]),以及一项对正常发育儿童的观察性研究(n = 32,14名男性,平均年龄 = 5.7个月[标准差 = 0.8])。GMFM - 66 - IS和对照工具(根据研究情况,为《贝利婴幼儿发展量表》第三版[贝利 - III]或《贝利婴幼儿发展量表》第四版[贝利 - 4]中的粗大运动子测验)在基线和3个月后进行施测。对照组基于神经损伤、粗大运动变化的临床评分和CP状态。计算相关性(r)和回归调整后的标准化平均差异(赫奇斯g值)。
GMFM - 66 - IS得分与贝利得分在基线时(r = 0.83)、3个月后(r = 0.88)以及整个时间段(r = 0.83)均具有相关性。轻度损伤儿童在基线时(g = 0.87)和3个月后(g = 0.95)的GMFM - 66 - IS平均得分更高。被评定为粗大运动变化大于预期的儿童,其GMFM - 66 - IS变化平均得分高于变化小于预期的儿童(g = 0.62)。正常发育儿童的GMFM - 66 - IS变化平均得分更高(g = 1.00)。
GMFM - 66 - IS得分有强有力的结构效度和中等反应度的证据支持。